You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 402Biotin 62FITC 50PE 48APC 41HRP 31Cy3 19PE/Cy5 19PE/Cy7 18PE/Cy5.5 13Pacific Blue 13PerCP/Cy5.5 13APC/Cy7 12Fluoro488 12Fluoro550 12Fluoro594 12Fluoro647 12PerCP 11APC/Cy5.5 10BF405 10BF488 10BF647 10BF700 10Cy5 10PerCP/Cy7 10BF350 9BF555 9BF594 9BF680 9BF750 9Cy5.5 9Cy7 9RBITC 9AP 7ALP 6IRDye800 6PE/Texas Red 2RPE 2AE 1Elab Fluor Red 780 1Elab Fluor Violet 450 1PF488P 1PF647P 1SureLight 488 1Tri-Color 1mFV450 1mFV540 1
Biologically Active
Featured Product
IL-2 Antibody [orb2310423]IHC
Human
Mouse
Monoclonal
Unconjugated
100 μg, 20 μg, 100 μg (without BSA and Azide)- IL-2 Antibody [orb2310426]
IHC
Human
Mouse
Monoclonal
Unconjugated
100 μg (without BSA and Azide), 20 μg, 100 μg - IL-2 Antibody [orb2312195]
IHC
Human
Mouse
Monoclonal
Unconjugated
100 μg (without BSA and Azide), 100 μg, 20 μg - Item 1 of 1
Human IL-2 [orb3002347]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.5 KDa. Observed: 14 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human IL-2 [orb3002496]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.5 KDa. Observed: 14 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg - Human IL-2RG [orb3002329]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 55.4 KDa. Observed: 85-100 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-2 [orb3002442]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 16.4 KDa. Observed: 14-18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse IL-2 [orb3002463]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 17.4 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Human IL-2 [orb3002229]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.5 KDa. Observed: 16&18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg
